Global Fibrin Glue Market- Industry Analysis and forecast 2019-2027: By Application, Product, and Region.

Global Fibrin Glue Market size was valued US$ XX Bn. in 2019 and the total revenue is expected to grow at 12.02% through 2019 to 2027, reaching nearly US$ XX Bn.   Global Fibrin Glue Market To know about the Research Methodology :- Request Free Sample Report The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis. Fibrin glue also called as fibrin sealant is a hemostatic agent, used in surgical procedure as adhesion material to close wounds by making fibrin clot. Fibrin glue is derived from human and animal blood products. Fibrin glue main ingredients contain purified thrombin (Enzyme) and purified fibrinogen (Protein). The fibrin glue market dynamics are thoroughly studied and explained in the MMR report, which helps to understand emerging market trends, drivers, restraints, opportunities, and challenges at the global and regional level for the fibrin glue market globally. The improved healthcare industry in the developing economies provide huge growth opportunities for the global market for fibrin glue. The overall healthcare sector is undergoing rapid changes in the developing economies thanks to growing government expenditure, upsurge in the number of surgeries, rising number of hospitals, and mounting healthcare awareness. Emerging countries offer suitable opportunities for the growth of the fibrin glue market globally. In emerging economies such as Brazil, India, China, and Mexico, the government is increasing expenditure on healthcare. As per the 2014 World Bank, Brazil spent nearly 8.3% of US$ 2.456 trillion GDP on healthcare. However, the market for fibrin glue has been facing certain challenges, for instance, stringent regulatory requirements and growing minimally invasive procedures, which may hinder the growth of the global market, during 2019-2027. By application, cardiac surgery segment was valued US$ XX Mn. in 2019 and is expected to reach US$ XX Mn. by 2027 at a CAGR of XX.30% over the forecast period. Fibrin based glue is used for hemostasis and tissue adherence throughout cardiac surgeries to avoid the loss of blood, which is one of the most serious issues encountered while acting a cardiac surgery. Likewise, the MMR report will provide an accurate prediction of the contribution of the various segments to the growth of the fibrin glue market size. The report also offers a brief analysis of the major regions in the fibrin glue market, namely, Europe, North America, APAC, South America, and the MEA. Among this, North America accounted for the largest fibrin glue market share in 2019, with a market value of US$ XX Mn; the regional market is expected to register a CAGR of XX.10% during 2019-2027. This is attributed to the increase in the number of surgical procedures. Furthermore, APAC is likely to display a significant growth in the fibrin glue market during 2019-2027. Emerging countries like China & India are expected to play a major role in the growth of Asian fibrin glue market. A chance of pollution of glue with viruses in human is one of the disadvantages of fibrin glue which can be an inhibitor for the market for fibrin glue. In recent years, major players in the fibrin glue market have taken several strategic measures, like facility expansions and partnerships. In 2018, a worldwide leader in advancing surgical invention, Baxter Company unveiled the latest design improvements for its fibrin sealant product. The Tisseel Prima syringe was exposed at the 2018 AAGL (American Association of Gynecologic Laparoscopists) meeting. Also, in 2019, to aid surgeons manage bleeding through surgery; Johnson & Johnson Medical Devices Companies declared that Ethicon launched VISTASEAL Fibrin Sealant (Human). The objective of the report is to present a comprehensive analysis of the Global Fibrin Glue Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Fibrin Glue Market dynamics, structure by analyzing the market segments and projects the Global Fibrin Glue Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Fibrin Glue Market make the report investor’s guide.

Scope of the Global Fibrin Glue Market: Inquire before buying

Global Fibrin Glue Market, By Application

• Cardiac surgery • Pulmonary surgery • Burn bleeding • Vascular surgeries • Orthopedic surgeries • Lacerations of liver and spleen • Neurosurgery • Plastic surgery • General surgery • Wound management

Global Fibrin Glue Market, By Product

• Viral Inactivation • Autologous Donation • Recombinant Production • Others

Global Fibrin Glue Market, By Region

• Asia Pacific  India  China  Japan  South Korea  Australia  Indonesia  Malaysia  Vietnam  Rest of Asia • North America  U.S.  Canada • Europe  U.K  Germany  France  Russia  Spain  Italy  Sweden • South America  Mexico  Brazil  Rest of South America • Middle East & Africa  GCC  South Africa  Rest of MEA

Key players operating in Global Fibrin Glue Market

• Vivostat A/S • Kaketsuken • Johnson & Johnson • Baxter International Inc. • CSL Behring • STB Lifesaving Technologies • Zimmer Biomet Holdings, Inc. • Takeda Pharmaceutical Company Limited • Mallinckrodt Plc • Shanghai RAAS Blood Products Co. Ltd. • Hualan Biological Engineering Inc. • Bayer • Shanghai RAAS • Cryolife • Haemcure Corporation • Omrix Biopharmaceutical, Inc. • Interpore Cross.
Global Fibrin Glue Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Fibrin Glue Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Fibrin Glue Market Analysis and Forecast 6.1. Fibrin Glue Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Fibrin Glue Market Analysis and Forecast, By Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Fibrin Glue Market Value Share Analysis, By Product 7.4. Fibrin Glue Market Size (US$ Bn) Forecast, By Product 7.5. Fibrin Glue Market Analysis, By Product 7.6. Fibrin Glue Market Attractiveness Analysis, By Product 8. Global Fibrin Glue Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Fibrin Glue Market Value Share Analysis, By Application 8.4. Fibrin Glue Market Size (US$ Bn) Forecast, By Application 8.5. Fibrin Glue Market Analysis, By Application 8.6. Fibrin Glue Market Attractiveness Analysis, By Application 9. Global Fibrin Glue Market Analysis, by Region 9.1. Fibrin Glue Market Value Share Analysis, by Region 9.2. Fibrin Glue Market Size (US$ Bn) Forecast, by Region 9.3. Fibrin Glue Market Attractiveness Analysis, by Region 10. North America Fibrin Glue Market Analysis 10.1. Key Findings 10.2. North America Fibrin Glue Market Overview 10.3. North America Fibrin Glue Market Value Share Analysis, By Product 10.4. North America Fibrin Glue Market Forecast, By Product 10.4.1. Viral Inactivation 10.4.2. Autologous Donation 10.4.3. Recombinant Production 10.4.4. Other 10.5. North America Fibrin Glue Market Value Share Analysis, By Application 10.6. North America Fibrin Glue Market Forecast, By Application 10.6.1. Cardiac surgery 10.6.2. Pulmonary surgery 10.6.3. Burn bleeding 10.6.4. Vascular surgeries 10.6.5. Orthopedic surgeries 10.6.6. Lacerations of liver and spleen 10.6.7. Neurosurgery 10.6.8. Plastic surgery 10.6.9. General surgery 10.6.10. Wound management 10.7. North America Fibrin Glue Market Value Share Analysis, by Country 10.8. North America Fibrin Glue Market Forecast, by Country 10.8.1. USA 10.8.2. Canada 10.9. North America Fibrin Glue Market Analysis, by Country 10.10. USA Fibrin Glue Market Forecast, By Product 10.10.1. Viral Inactivation 10.10.2. Autologous Donation 10.10.3. Recombinant Production 10.10.4. Other 10.11. USA Fibrin Glue Market Forecast, By Application 10.11.1. Cardiac surgery 10.11.2. Pulmonary surgery 10.11.3. Burn bleeding 10.11.4. Vascular surgeries 10.11.5. Orthopedic surgeries 10.11.6. Lacerations of liver and spleen 10.11.7. Neurosurgery 10.11.8. Plastic surgery 10.11.9. General surgery 10.11.10. Wound management 10.12. Canada Fibrin Glue Market Forecast, By Product 10.12.1. Viral Inactivation 10.12.2. Autologous Donation 10.12.3. Recombinant Production 10.12.4. Other 10.13. Canada Fibrin Glue Market Forecast, By Application 10.13.1. Cardiac surgery 10.13.2. Pulmonary surgery 10.13.3. Burn bleeding 10.13.4. Vascular surgeries 10.13.5. Orthopedic surgeries 10.13.6. Lacerations of liver and spleen 10.13.7. Neurosurgery 10.13.8. Plastic surgery 10.13.9. General surgery 10.13.10. Wound management 10.14. North America Fibrin Glue Market Attractiveness Analysis 10.14.1. By Product 10.14.2. By Application 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Developments 11. Europe Fibrin Glue Market Analysis 11.1. Key Findings 11.2. Europe Fibrin Glue Market Overview 11.3. Europe Fibrin Glue Market Value Share Analysis, By Product 11.4. Europe Fibrin Glue Market Forecast, By Product 11.4.1. Viral Inactivation 11.4.2. Autologous Donation 11.4.3. Recombinant Production 11.4.4. Other 11.5. Europe Fibrin Glue Market Value Share Analysis, By Application 11.6. Europe Fibrin Glue Market Forecast, By Application 11.6.1. Cardiac surgery 11.6.2. Pulmonary surgery 11.6.3. Burn bleeding 11.6.4. Vascular surgeries 11.6.5. Orthopedic surgeries 11.6.6. Lacerations of liver and spleen 11.6.7. Neurosurgery 11.6.8. Plastic surgery 11.6.9. General surgery 11.6.10. Wound management 11.7. Europe Fibrin Glue Market Value Share Analysis, by Country 11.8. Europe Fibrin Glue Market Forecast, by Country 11.8.1. UK 11.8.2. France 11.8.3. Germany 11.8.4. Italy 11.8.5. Spain 11.8.6. Norway 11.8.7. Russia 11.9. Europe Fibrin Glue Market Analysis, by Country 11.10. UK Fibrin Glue Market Forecast, By Product 11.10.1. Viral Inactivation 11.10.2. Autologous Donation 11.10.3. Recombinant Production 11.10.4. Other 11.11. UK Fibrin Glue Market Forecast, By Application 11.11.1. Cardiac surgery 11.11.2. Pulmonary surgery 11.11.3. Burn bleeding 11.11.4. Vascular surgeries 11.11.5. Orthopedic surgeries 11.11.6. Lacerations of liver and spleen 11.11.7. Neurosurgery 11.11.8. Plastic surgery 11.11.9. General surgery 11.11.10. Wound management 11.12. France Fibrin Glue Market Forecast, By Product 11.12.1. Viral Inactivation 11.12.2. Autologous Donation 11.12.3. Recombinant Production 11.12.4. Other 11.13. France Fibrin Glue Market Forecast, By Application 11.13.1. Cardiac surgery 11.13.2. Pulmonary surgery 11.13.3. Burn bleeding 11.13.4. Vascular surgeries 11.13.5. Orthopedic surgeries 11.13.6. Lacerations of liver and spleen 11.13.7. Neurosurgery 11.13.8. Plastic surgery 11.13.9. General surgery 11.13.10. Wound management 11.14. Germany Fibrin Glue Market Forecast, By Product 11.14.1. Viral Inactivation 11.14.2. Autologous Donation 11.14.3. Recombinant Production 11.14.4. Other 11.15. Germany Fibrin Glue Market Forecast, By Application 11.15.1. Cardiac surgery 11.15.2. Pulmonary surgery 11.15.3. Burn bleeding 11.15.4. Vascular surgeries 11.15.5. Orthopedic surgeries 11.15.6. Lacerations of liver and spleen 11.15.7. Neurosurgery 11.15.8. Plastic surgery 11.15.9. General surgery 11.15.10. Wound management 11.16. Italy Fibrin Glue Market Forecast, By Product 11.16.1. Viral Inactivation 11.16.2. Autologous Donation 11.16.3. Recombinant Production 11.16.4. Other 11.17. Italy Fibrin Glue Market Forecast, By Application 11.17.1. Cardiac surgery 11.17.2. Pulmonary surgery 11.17.3. Burn bleeding 11.17.4. Vascular surgeries 11.17.5. Orthopedic surgeries 11.17.6. Lacerations of liver and spleen 11.17.7. Neurosurgery 11.17.8. Plastic surgery 11.17.9. General surgery 11.17.10. Wound management 11.18. Spain Fibrin Glue Market Forecast, By Product 11.18.1. Viral Inactivation 11.18.2. Autologous Donation 11.18.3. Recombinant Production 11.18.4. Other 11.19. Spain Fibrin Glue Market Forecast, By Application 11.19.1. Cardiac surgery 11.19.2. Pulmonary surgery 11.19.3. Burn bleeding 11.19.4. Vascular surgeries 11.19.5. Orthopedic surgeries 11.19.6. Lacerations of liver and spleen 11.19.7. Neurosurgery 11.19.8. Plastic surgery 11.19.9. General surgery 11.19.10. Wound management 11.20. Norway Fibrin Glue Market Forecast, By Product 11.20.1. Viral Inactivation 11.20.2. Autologous Donation 11.20.3. Recombinant Production 11.20.4. Other 11.21. Norway Fibrin Glue Market Forecast, By Application 11.21.1. Cardiac surgery 11.21.2. Pulmonary surgery 11.21.3. Burn bleeding 11.21.4. Vascular surgeries 11.21.5. Orthopedic surgeries 11.21.6. Lacerations of liver and spleen 11.21.7. Neurosurgery 11.21.8. Plastic surgery 11.21.9. General surgery 11.21.10. Wound management 11.22. Russia Fibrin Glue Market Forecast, By Product 11.22.1. Viral Inactivation 11.22.2. Autologous Donation 11.22.3. Recombinant Production 11.22.4. Other 11.23. Russia Fibrin Glue Market Forecast, By Application 11.23.1. Cardiac surgery 11.23.2. Pulmonary surgery 11.23.3. Burn bleeding 11.23.4. Vascular surgeries 11.23.5. Orthopedic surgeries 11.23.6. Lacerations of liver and spleen 11.23.7. Neurosurgery 11.23.8. Plastic surgery 11.23.9. General surgery 11.23.10. Wound management 11.24. Europe Fibrin Glue Market Attractiveness Analysis 11.24.1. By Product 11.24.2. By Application 11.25. PEST Analysis 11.26. Key Trends 11.27. Key Developments 12. Asia Pacific Fibrin Glue Market Analysis 12.1. Key Findings 12.2. Asia Pacific Fibrin Glue Market Overview 12.3. Asia Pacific Fibrin Glue Market Value Share Analysis, By Product 12.4. Asia Pacific Fibrin Glue Market Forecast, By Product 12.4.1. Viral Inactivation 12.4.2. Autologous Donation 12.4.3. Recombinant Production 12.4.4. Other 12.5. Asia Pacific Fibrin Glue Market Value Share Analysis, By Application 12.6. Asia Pacific Fibrin Glue Market Forecast, By Application 12.6.1. Cardiac surgery 12.6.2. Pulmonary surgery 12.6.3. Burn bleeding 12.6.4. Vascular surgeries 12.6.5. Orthopedic surgeries 12.6.6. Lacerations of liver and spleen 12.6.7. Neurosurgery 12.6.8. Plastic surgery 12.6.9. General surgery 12.6.10. Wound management 12.7. Asia Pacific Fibrin Glue Market Value Share Analysis, by Country 12.8. Asia Pacific Fibrin Glue Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. South Korea 12.8.5. Australia 12.8.6. Malaysia 12.8.7. Indonesia 12.8.8. Vietnam 12.9. Asia Pacific Fibrin Glue Market Analysis, by Country 12.10. China Fibrin Glue Market Forecast, By Product 12.10.1. Viral Inactivation 12.10.2. Autologous Donation 12.10.3. Recombinant Production 12.10.4. Other 12.11. China Fibrin Glue Market Forecast, By Application 12.11.1. Cardiac surgery 12.11.2. Pulmonary surgery 12.11.3. Burn bleeding 12.11.4. Vascular surgeries 12.11.5. Orthopedic surgeries 12.11.6. Lacerations of liver and spleen 12.11.7. Neurosurgery 12.11.8. Plastic surgery 12.11.9. General surgery 12.11.10. Wound management 12.12. India Fibrin Glue Market Forecast, By Product 12.12.1. Viral Inactivation 12.12.2. Autologous Donation 12.12.3. Recombinant Production 12.12.4. Other 12.13. India Fibrin Glue Market Forecast, By Application 12.13.1. Cardiac surgery 12.13.2. Pulmonary surgery 12.13.3. Burn bleeding 12.13.4. Vascular surgeries 12.13.5. Orthopedic surgeries 12.13.6. Lacerations of liver and spleen 12.13.7. Neurosurgery 12.13.8. Plastic surgery 12.13.9. General surgery 12.13.10. Wound management 12.14. Japan Fibrin Glue Market Forecast, By Product 12.14.1. Viral Inactivation 12.14.2. Autologous Donation 12.14.3. Recombinant Production 12.14.4. Other 12.15. Japan Fibrin Glue Market Forecast, By Application 12.15.1. Cardiac surgery 12.15.2. Pulmonary surgery 12.15.3. Burn bleeding 12.15.4. Vascular surgeries 12.15.5. Orthopedic surgeries 12.15.6. Lacerations of liver and spleen 12.15.7. Neurosurgery 12.15.8. Plastic surgery 12.15.9. General surgery 12.15.10. Wound management 12.16. South Korea Fibrin Glue Market Forecast, By Product 12.16.1. Viral Inactivation 12.16.2. Autologous Donation 12.16.3. Recombinant Production 12.16.4. Other 12.17. South Korea Fibrin Glue Market Forecast, By Application 12.17.1. Cardiac surgery 12.17.2. Pulmonary surgery 12.17.3. Burn bleeding 12.17.4. Vascular surgeries 12.17.5. Orthopedic surgeries 12.17.6. Lacerations of liver and spleen 12.17.7. Neurosurgery 12.17.8. Plastic surgery 12.17.9. General surgery 12.17.10. Wound management 12.18. Australia Fibrin Glue Market Forecast, By Product 12.18.1. Viral Inactivation 12.18.2. Autologous Donation 12.18.3. Recombinant Production 12.18.4. Other 12.19. Australia Fibrin Glue Market Forecast, By Application 12.19.1. Cardiac surgery 12.19.2. Pulmonary surgery 12.19.3. Burn bleeding 12.19.4. Vascular surgeries 12.19.5. Orthopedic surgeries 12.19.6. Lacerations of liver and spleen 12.19.7. Neurosurgery 12.19.8. Plastic surgery 12.19.9. General surgery 12.19.10. Wound management 12.20. Malaysia Fibrin Glue Market Forecast, By Product 12.20.1. Viral Inactivation 12.20.2. Autologous Donation 12.20.3. Recombinant Production 12.20.4. Other 12.21. Malaysia Fibrin Glue Market Forecast, By Application 12.21.1. Cardiac surgery 12.21.2. Pulmonary surgery 12.21.3. Burn bleeding 12.21.4. Vascular surgeries 12.21.5. Orthopedic surgeries 12.21.6. Lacerations of liver and spleen 12.21.7. Neurosurgery 12.21.8. Plastic surgery 12.21.9. General surgery 12.21.10. Wound management 12.22. Indonesia Fibrin Glue Market Forecast, By Product 12.22.1. Viral Inactivation 12.22.2. Autologous Donation 12.22.3. Recombinant Production 12.22.4. Other 12.23. Indonesia Fibrin Glue Market Forecast, By Application 12.23.1. Cardiac surgery 12.23.2. Pulmonary surgery 12.23.3. Burn bleeding 12.23.4. Vascular surgeries 12.23.5. Orthopedic surgeries 12.23.6. Lacerations of liver and spleen 12.23.7. Neurosurgery 12.23.8. Plastic surgery 12.23.9. General surgery 12.23.10. Wound management 12.24. Vietnam Fibrin Glue Market Forecast, By Product 12.24.1. Viral Inactivation 12.24.2. Autologous Donation 12.24.3. Recombinant Production 12.24.4. Other 12.25. Vietnam Fibrin Glue Market Forecast, By Application 12.25.1. Cardiac surgery 12.25.2. Pulmonary surgery 12.25.3. Burn bleeding 12.25.4. Vascular surgeries 12.25.5. Orthopedic surgeries 12.25.6. Lacerations of liver and spleen 12.25.7. Neurosurgery 12.25.8. Plastic surgery 12.25.9. General surgery 12.25.10. Wound management 12.26. Asia Pacific Fibrin Glue Market Attractiveness Analysis 12.26.1. By Product 12.26.2. By Application 12.27. PEST Analysis 12.28. Key Trends 12.29. Key Developments 13. Middle East & Africa Fibrin Glue Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Fibrin Glue Market Overview 13.3. Middle East & Africa Fibrin Glue Market Value Share Analysis, By Product 13.4. Middle East & Africa Fibrin Glue Market Forecast, By Product 13.4.1. Viral Inactivation 13.4.2. Autologous Donation 13.4.3. Recombinant Production 13.4.4. Other 13.5. Middle East & Africa Fibrin Glue Market Value Share Analysis, By Application 13.6. Middle East & Africa Fibrin Glue Market Forecast, By Application 13.6.1. Cardiac surgery 13.6.2. Pulmonary surgery 13.6.3. Burn bleeding 13.6.4. Vascular surgeries 13.6.5. Orthopedic surgeries 13.6.6. Lacerations of liver and spleen 13.6.7. Neurosurgery 13.6.8. Plastic surgery 13.6.9. General surgery 13.6.10. Wound management 13.7. Middle East & Africa Fibrin Glue Market Value Share Analysis, by Country 13.8. Middle East & Africa Fibrin Glue Market Forecast, by Country 13.8.1. GCC Countries 13.8.2. South Africa 13.8.3. Nigeria 13.8.4. Egypt 13.9. Middle East & Africa Fibrin Glue Market Analysis, by Country 13.10. GCC Fibrin Glue Market Forecast, By Product 13.10.1. Viral Inactivation 13.10.2. Autologous Donation 13.10.3. Recombinant Production 13.10.4. Other 13.11. GCC Fibrin Glue Market Forecast, By Application 13.11.1. Cardiac surgery 13.11.2. Pulmonary surgery 13.11.3. Burn bleeding 13.11.4. Vascular surgeries 13.11.5. Orthopedic surgeries 13.11.6. Lacerations of liver and spleen 13.11.7. Neurosurgery 13.11.8. Plastic surgery 13.11.9. General surgery 13.11.10. Wound management 13.12. South Africa Fibrin Glue Market Forecast, By Product 13.12.1. Viral Inactivation 13.12.2. Autologous Donation 13.12.3. Recombinant Production 13.12.4. Other 13.13. South Africa Fibrin Glue Market Forecast, By Application 13.13.1. Cardiac surgery 13.13.2. Pulmonary surgery 13.13.3. Burn bleeding 13.13.4. Vascular surgeries 13.13.5. Orthopedic surgeries 13.13.6. Lacerations of liver and spleen 13.13.7. Neurosurgery 13.13.8. Plastic surgery 13.13.9. General surgery 13.13.10. Wound management 13.14. Nigeria Fibrin Glue Market Forecast, By Product 13.14.1. Viral Inactivation 13.14.2. Autologous Donation 13.14.3. Recombinant Production 13.14.4. Other 13.15. Nigeria Fibrin Glue Market Forecast, By Application 13.15.1. Cardiac surgery 13.15.2. Pulmonary surgery 13.15.3. Burn bleeding 13.15.4. Vascular surgeries 13.15.5. Orthopedic surgeries 13.15.6. Lacerations of liver and spleen 13.15.7. Neurosurgery 13.15.8. Plastic surgery 13.15.9. General surgery 13.15.10. Wound management 13.16. Egypt Fibrin Glue Market Forecast, By Product 13.16.1. Viral Inactivation 13.16.2. Autologous Donation 13.16.3. Recombinant Production 13.16.4. Other 13.17. Egypt Fibrin Glue Market Forecast, By Application 13.17.1. Cardiac surgery 13.17.2. Pulmonary surgery 13.17.3. Burn bleeding 13.17.4. Vascular surgeries 13.17.5. Orthopedic surgeries 13.17.6. Lacerations of liver and spleen 13.17.7. Neurosurgery 13.17.8. Plastic surgery 13.17.9. General surgery 13.17.10. Wound management 13.18. Middle East & Africa Fibrin Glue Market Attractiveness Analysis 13.18.1. By Product 13.18.2. By Application 13.19. PEST Analysis 13.20. Key Trends 13.21. Key Developments 14. South America Fibrin Glue Market Analysis 14.1. Key Findings 14.2. South America Fibrin Glue Market Overview 14.3. South America Fibrin Glue Market Value Share Analysis, By Product 14.4. South America Fibrin Glue Market Forecast, By Product 14.4.1. Viral Inactivation 14.4.2. Autologous Donation 14.4.3. Recombinant Production 14.4.4. Other 14.5. South America Fibrin Glue Market Value Share Analysis, By Application 14.6. South America Fibrin Glue Market Forecast, By Application 14.6.1. Cardiac surgery 14.6.2. Pulmonary surgery 14.6.3. Burn bleeding 14.6.4. Vascular surgeries 14.6.5. Orthopedic surgeries 14.6.6. Lacerations of liver and spleen 14.6.7. Neurosurgery 14.6.8. Plastic surgery 14.6.9. General surgery 14.6.10. Wound management 14.7. South America Fibrin Glue Market Value Share Analysis, by Country 14.8. South America Fibrin Glue Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Argentina 14.9. South America Fibrin Glue Market Analysis, by Country 14.10. Brazil Fibrin Glue Market Forecast, By Product 14.10.1. Viral Inactivation 14.10.2. Autologous Donation 14.10.3. Recombinant Production 14.10.4. Other 14.11. Brazil Fibrin Glue Market Forecast, By Application 14.11.1. Cardiac surgery 14.11.2. Pulmonary surgery 14.11.3. Burn bleeding 14.11.4. Vascular surgeries 14.11.5. Orthopedic surgeries 14.11.6. Lacerations of liver and spleen 14.11.7. Neurosurgery 14.11.8. Plastic surgery 14.11.9. General surgery 14.11.10. Wound management 14.12. Mexico Fibrin Glue Market Forecast, By Product 14.12.1. Viral Inactivation 14.12.2. Autologous Donation 14.12.3. Recombinant Production 14.12.4. Other 14.13. Mexico Fibrin Glue Market Forecast, By Application 14.13.1. Cardiac surgery 14.13.2. Pulmonary surgery 14.13.3. Burn bleeding 14.13.4. Vascular surgeries 14.13.5. Orthopedic surgeries 14.13.6. Lacerations of liver and spleen 14.13.7. Neurosurgery 14.13.8. Plastic surgery 14.13.9. General surgery 14.13.10. Wound management 14.14. Argentina Fibrin Glue Market Forecast, By Product 14.14.1. Viral Inactivation 14.14.2. Autologous Donation 14.14.3. Recombinant Production 14.14.4. Other 14.15. Argentina Fibrin Glue Market Forecast, By Application 14.15.1. Cardiac surgery 14.15.2. Pulmonary surgery 14.15.3. Burn bleeding 14.15.4. Vascular surgeries 14.15.5. Orthopedic surgeries 14.15.6. Lacerations of liver and spleen 14.15.7. Neurosurgery 14.15.8. Plastic surgery 14.15.9. General surgery 14.15.10. Wound management 14.16. South America Fibrin Glue Market Attractiveness Analysis 14.16.1. By Product 14.16.2. By Application 14.17. PEST Analysis 14.18. Key Trends 14.19. Key Developments 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Vehicles 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Vivostat A/S. 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Kaketsuken 15.3.3. Johnson & Johnson 15.3.4. Baxter International Inc. 15.3.5. CSL Behring 15.3.6. STB Lifesaving Technologies 15.3.7. Zimmer Biomet Holdings, Inc. 15.3.8. Takeda Pharmaceutical Company Limited 15.3.9. Mallinckrodt Plc 15.3.10. Shanghai RAAS Blood Products Co. Ltd. 15.3.11. Hualan Biological Engineering Inc. 15.3.12. Bayer 15.3.13. Shanghai RAAS 15.3.14. Cryolife 15.3.15. Haemcure Corporation 15.3.16. Omrix Biopharmaceutical, Inc. 15.3.17. Interpore Cross. 16. Primary Key Insights

About This Report

Report ID71575
Category Healthcare
Published DateSeptember 2020
Updated Date
Contact Us